Putting Patients First Blog

FEBRUARY 5, 2024

In addition, the NHC hosts ad-hoc meetings, events, webinars, and briefings on relevant and timely topics. Our website is home to training and informational modules, tools, and various webinar series. To view our 2024 policy priorities, click here.

Documentation 59

Documentation Communication 59

pharmaphorum

NOVEMBER 15, 2021

That was among the key messages from speakers at a joint European Forum for Good Clinical Practice (EFGCP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) webinar, held last week. This should cover the entire process, “starting with the writing, the review of the document, and its dissemination”.

Documentation 98

Documentation Communication Hospitals 98

epicur

DECEMBER 19, 2022

The FDA recently finalized regulatory guidance for compounded animal medications from bulk drug substances for use in non-food-producing animals, impacting the way compounded drugs can be used, documented, ordered, and prescribed. Pharmacists must document why an FDA-approved or indexed product is not being used to compound the medication.

Compounding 52

Compounding Compounding Pharmacies Documentation Dosage 52

Birth Control Pharmacist

FEBRUARY 12, 2024

Pharmacists must be familiar with billing codes, insurance coverage policies, and documentation requirements to facilitate seamless transactions and ensure fair compensation for their services.

Documentation 52

Documentation 52

pharmaphorum

FEBRUARY 11, 2021

In a recent webinar from pharmaphorum, the National Institute for Health Research (NIHR) outlined why and how it has developed a new approach to engage with patients while complying with national regulations, such as those set out in the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice.

Communication 101

Communication Documentation Hospitals Vaccines 101

Express Pharma

OCTOBER 4, 2023

The comparison between the existing Schedule M and the draft upgraded version (as outlined in the presentation given by Dr Eswara Reddy, JDCI, CDSCO at one of these webinars) would require considerable expenditure and time. These workshops are set to continue over the next few months.

Packaging 80

Packaging Documentation 80

Board Vitals - Pharmacist

APRIL 22, 2022

Events sponsored by an accredited CME provider include national, regional, or local conferences, workshops, seminars, journal clubs, simulation labs, and live webinars. This includes print, audiovisual, and internet materials such as podcasts; CD-ROMs; DVDs; archived webinars; CME question banks ; and other web-based activities.

Documentation 52

Documentation 52

epicur

AUGUST 8, 2023

Some of the biggest changes that GFI #256 brings include: Increased documentation for patient-specific prescriptions Limitations to available 503A office-stock drugs Although veterinary professionals were aware of the impending changes with GFI for months, many have been left scrambling since it went into effect in April.

Compounding 52

Compounding Documentation Compounding Pharmacies Packaging 52

pharmaphorum

JULY 13, 2021

Among the recommendations are that more public money should be made available to mental health tech start-ups to encourage the sector to grow, and efforts should be made to build consortia between companies, the NHS digital innovation agency NHSX, medical charities, and government, according to the document.

Documentation 124

Documentation 124

pharmaphorum

OCTOBER 27, 2022

Webinars – Webinars, whether live streamed or on-demand, can be used for communication with HCPs, HCOs, and POs. A company is responsible for the content of webinars and should take reasonable steps to ensure the audience is targeted and well defined.

Communication 98

Communication Pharmaceutical Manufacturing Packaging Documentation 98

Pharmaceutical Technology

FEBRUARY 24, 2023

But the EU draft document says that the changes will make medicines more affordable, improve unequal access to medicines across the EU, and fulfil unmet patient needs. EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies.

Biosimilars 64

Biosimilars Documentation 64

Safe Biologics

FEBRUARY 1, 2024

It examines the likely negative effects of IRA’s price negotiation provisions, which allow the Centers for Medicare and Medicaid Services to negotiate prices of certain costly drugs, including many biologic medicines.

Biosimilars 130

Biosimilars Documentation Drug Pricing 130

FDA Law Blog: Biosimilars

JUNE 21, 2023

As acknowledged in the Strategic Priorities document, certain demographic groups may have limited access to necessary treatments and diagnostics. For those who are interested in learning more about the decentralized clinical trial draft guidance, please check out the FDA’s webinar on June 20, 2023.

Documentation 45

Documentation Hospitals 45

FDA Law Blog: Biosimilars

OCTOBER 10, 2023

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — As we recently blogged , FDA released three draft guidance documents to help enhance the predictability, consistency, and transparency of the 510(k) program. One of these documents focuses on “ Evidentiary Expectations for 510(k) Implant Devices.”

Documentation 45

Documentation Labelling Communication 45

assurecare

JULY 20, 2023

To navigate these changes, healthcare organizations should focus on accurate documentation and reporting of quality metrics, implement care coordination and patient engagement strategies, shift from volume to value-based measures, enhance data management and interoperability, and align RCM with alternative payment models.

Documentation 40

Documentation 40

PharmaState Academy

MARCH 30, 2023

He is an awe-inspiring peronality who has exceptional experiences in building and leading Institutional Sales, Key Account Management , Strategy & Planning , Market Access, Tender Business, New Product Inclusion, Document & Pricing strategy and much more.

Documentation 52

Documentation Communication 52

Big Molecule Watch

OCTOBER 2, 2023

For more information about pending challenges, visit our Goodwin IRA Resource page which includes our IRA Litigation Tracker and our recent webinar addressing updates in pending challenges and oral argument in the Chambers of Commerce case.

Drug Pricing 62

Drug Pricing Documentation 62

ID Stewardship

APRIL 13, 2023

An important accompanying document for Joint Commission standards are Critical Access Hospital Accreditation Survey Activity Guide, for which the January 2023 guide can be found here. The latest antimicrobial stewardship regulations from The Joint Commission went into effect in January 2023.

Hospitals 94

Hospitals Inpatient Documentation Communication 94

Pharma in Brief

JUNE 21, 2020

In addition to accepting written feedback on the revised Draft Guidelines until July 20, 2020 , the PMPRB has also scheduled a number of webinars : Public consultations with industry stakeholders (June 29) and the general public (July 8). The PMPRB has now produced revised Draft Guidelines. The consultation: next steps.

Biosimilars 40

Biosimilars Generic Medicine Dosage Documentation 40

Quality Matters

NOVEMBER 11, 2022

FDA and other global regulatory agencies have issued public health alerts and guidance documents for manufacturers. Beyond standards: Collaboration and knowledge-sharing resources Aside from providing reference and documentary standards, USP also offers numerous educational resources, trainings, workshops, webinars and toolkits.

Packaging 52

Packaging Documentation Compounding Diabetes 52

Drug Channels

DECEMBER 14, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. I document this disappointing state of affairs below. Click here to see the original post and comments from July 2021. I’m sad to report that this year’s analysis is skimpier than usual.

Documentation 81

Documentation 81

Pharma Leaders

JUNE 27, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

JUNE 22, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 19, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 17, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Diabetes 52

Diabetes Documentation 52

Pharma Leaders

MAY 12, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Drug Development 52

Drug Development Documentation 52

Pharma Leaders

MAY 11, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 9, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 8, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 5, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 3, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

MAY 1, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

APRIL 20, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

APRIL 18, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

APRIL 14, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

APRIL 7, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52

Pharma Leaders

APRIL 4, 2023

You can count on Drug Industry Daily for insightful, accurate articles supported by links to additional key documents, such as FDA guidances and comments, warning letters, full texts of proposed legislation, Federal Register postings, GAO reports and more.

Documentation 52

Documentation 52